The potential role of cyclin-dependent kinase 5 in focal cortical dysplasia

Developmental Neuroscience

Volumn 30, Issue 1-3, 2007, Pages 96-104

  Sen, Arjune ^a,c   Thom, Maria ^a   Nikolić, Margareta ^b   Sisodiya, Sanjay M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Cyclin dependent kinase 5; Epilepsy; Focal cortical dysplasia; p35; Reelin

Indexed keywords

CYCLIN DEPENDENT KINASE 5; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN P35; REELIN;

ALZHEIMER DISEASE; BRAIN DEVELOPMENT; DYSPLASIA; FOCAL CORTICAL DYSPLASIA; HIPPOCAMPAL SCLEROSIS; HIPPOCAMPUS; HUMAN; MOLECULAR BIOLOGY; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY;

CELL CYCLE PROTEINS; CELL MOVEMENT; CEREBRAL CORTEX; CYCLIN-DEPENDENT KINASE 5; ENZYME ACTIVATION; EPILEPSY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MALFORMATIONS OF CORTICAL DEVELOPMENT; SIGNAL TRANSDUCTION;

EID: 37149016913     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109855     Document Type: Short Survey

References (54)

1. Angelo M, Plattner F, Irvine EE, Giese KP (2003): Improved reversal learning and altered fear conditioning in transgenic mice with regionally restricted p25 expression. Eur J Neurosci 18:423-431.
2. Beffert U, Weeber EJ, Morfini G, Ko J, Brady ST, Tsai LH, Sweatt JD, Herz J (2004): Reelin and cyclin-dependent kinase 5-dependent signals cooperate in regulating neuronal migration and synaptic transmission. J Neurosci 24:1897-1906.
3. Bothwell M, Giniger E (2000): Alzheimer's disease: neurodevelopment converges with neurodegeneration. Cell 102:271-273.
4. Calcagnotto ME, Paredes MF, Tihan T, Barbaro NM, Baraban SC (2005): Dysfunction of synaptic inhibition in epilepsy associated with focal cortical dysplasia. J Neurosci 25:9649-9657.
5. Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH (1997): Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18:29-42.
6. Chang BS, Lowenstein DH (2003): Epilepsy. N Engl J Med 349:1257-1266.
7. Cheng K, Ip NY (2003): Cdk5: a new player at synapses. Neurosignals 12:180-190.
8. Cheung ZH, Fu AK, Ip NY (2006): Synaptic roles of Cdk5: implications in higher cognitive functions and neurodegenerative diseases. Neuron 50:13-18.
9. Cotter D, Honavar M, Lovestone S, Raymond L, Kerwin R, Anderton B, Everall I (1999): Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortex. Acta Neuropathol (Berl) 98:465-472.
10. Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH (2003): Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40:471-483.
11. D'Arcangelo G (2006): Reelin mouse mutants as models of cortical development disorders. Epilepsy Behav 8:81-90.
12. Dhavan R, Tsai LH (2001): A decade of CDK5. Nat Rev Mol Cell Biol 2:749-759.
13. Fauser S, Schulze-Bonhage A, Honegger J, Carmona H, Huppertz HJ, Pantazis G, Rona S, Bast T, Strobl K, Steinhoff BJ, Korinthenberg R, Rating D, Volk B, Zentner J (2004): Focal cortical dysplasias: surgical outcome in 67 patients in relation to histological subtypes and dual pathology. Brain 127:2406-2418.
14. Finardi A, Gardoni F, Bassanini S, Lasio G, Cossu M, Tassi L, Caccia C, Taroni F, LoRusso G, Di Luca M, Battaglia G (2006): NMDA receptor composition differs among anatomically diverse malformations of cortical development. J Neuropathol Exp Neurol 65:883-893.
15. Garbelli R, Frassoni C, Ferrario A, Tassi L, Bramerio M, Spreafico R (2001): Cajal-Retzius cell density as marker of type of focal cortical dysplasia. Neuroreport 12:2767-2771.
16. Giese KP, Ris L, Plattner F (2005): Is there a role of the cyclin-dependent kinase 5 activator p25 in Alzheimer's disease? Neuroreport 16:1725-1730.
17. Gilmore EC, Herrup K (2001): Neocortical cell migration: GABAergic neurons and cells in layers I and VI move in a cyclin-dependent kinase 5-independent manner. J Neurosci 21:9690-9700.
18. Gilmore EC, Ohshima T, Goffinet AM, Kulkarni AB, Herrup K (1998): Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex. J Neurosci 18:6370-6377.
19. Keshvara L, Magdaleno S, Benhayon D, Curran T (2002): Cyclin-dependent kinase 5 phosphorylates disabled 1 independently of Reelin signaling. J Neurosci 22:4869-4877.
20. Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, Tsai LH (2001): p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 21:6758-6771.
21. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH (2000): Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360-364.
22. Miyata H, Chiang AC, Vinters HV (2004): Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Ann Neurol 56:510-519.
23. Mizuguchi M, Yamanouchi H, Becker LE, Itoh M, Takashima S (2002): Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia. Acta Neuropathol (Berl) 104:418-424.
24. Najm IM, Ying Z, Babb T, Mohamed A, Hadam J, LaPresto E, Wyllie E, Kotagal P, Bingaman W, Foldvary N, Morris H, Luders HO (2000): Epileptogenicity correlated with increased N-methyl-D-aspartate receptor subunit NR2A/B in human focal cortical dysplasia. Epilepsia 41:971-976.
25. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ, Kulkarni AB (1996): Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 93:11173-11178.
26. Palmini A, Najm I, Avanzini G, Babb T, Guerrini R, Foldvary-Schaefer N, Jackson G, Luders HO, Prayson R, Spreafico R, Vinters HV (2004): Terminology and classification of the cortical dysplasias. Neurology 62:S2-S8.
27. Patel LS, Wenzel HJ, Schwartzkroin PA (2004): Physiological and morphological characterization of dentate granule cells in the p35 knock-out mouse hippocampus: evidence for an epileptic circuit. J Neurosci 24:9005-9014.
28. Patrick GN, Zukerberg L, Nikolic M, de La Monte S, Dikkes P, Tsai LH (1999): Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402: 615-622.
29. Plattner F, Angelo M, Giese KP (2006): The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J Biol Chem 281:25457-25465.
30. Rakic S, Davis C, Molnar Z, Nikolic M, Parnavelas JG (2006): Role of p35/Cdk5 in preplate splitting in the developing cerebral cortex. Cereb Cortex 16(suppl 1):i35-i45.
31. Sen A, Thom M, Martinian L, Harding B, Cross JH, Nikolic M, Sisodiya SM (2007): Pathological tau tangles localise to focal cortical dysplasia in older patients. Epilepsia 48:1447-1454.
32. Sen A, Thom M, Martinian L, Jacobs T, Nikolic M, Sisodiya SM (2006): Deregulation of cdk5 in hippocampal sclerosis. J Neuropathol Exp Neurol 65:55-66.
33. Sen A, Thom M, Martinian L, Yogarajah M, Nikolic M, Sisodiya SM (2007): Increased immunoreactivity of cdk5 activators in hippocampal sclerosis. Neuroreport 18:511-516.
34. Shelton SB, Johnson GV (2004): Cyclin-dependent kinase-5 in neurodegeneration. J Neurochem 88:1313-1326.
35. Sisodiya SM (2004): Malformations of cortical development: burdens and insights from important causes of human epilepsy. Lancet Neurol 3:29-38.
36. Sisodiya SM, Martinian L, Scheffer GL, van der Valk P, Cross JH, Scheper RJ, Harding BN, Thom M (2003): Major vault protein, a marker of drug resistance, is upregulated in refractory epilepsy. Epilepsia 44:1388-1396.
37. Sisodiya SM, Thom M, Lin WR, Bajaj NP, Cross JH, Harding BN (2002): Abnormal expression of cdk5 in focal cortical dysplasia in humans. Neurosci Lett 328:217-220.
38. Tan TC, Valova VA, Malladi CS, Graham ME, Berven LA, Jupp OJ, Hansra G, McClure SJ, Sarcevic B, Boadle RA, Larsen MR, Cousin MA, Robinson PJ (2003): Cdk5 is essential for synaptic vesicle endocytosis. Nat Cell Biol 5:701-710.
39. Tanaka T, Serneo FF, Tseng HC, Kulkarni AB, Tsai LH, Gleeson JG (2004): Cdk5 phosphorylation of doublecortin ser297 regulates its effect on neuronal migration. Neuron 41: 215-227.
40. Tandon A, Yu H, Wang L, Rogaeva E, Sato C, Chishti MA, Kawarai T, Hasegawa H, Chen F, Davies P, Fraser PE, Westaway D, St George-Hyslop PH (2003): Brain levels of CDK5 activator p25 are not increased in Alzheimer's or other neurodegenerative diseases with neurofibrillary tangles. J Neurochem 86:572-581.
41. Taylor DC, Falconer MA, Bruton CJ, Corsellis JA (1971): Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 34:369-387.
42. Thom M, Harding BN, Lin WR, Martinian L, Cross H, Sisodiya SM (2003): Cajal-Retzius cells, inhibitory interneuronal populations and neuropeptide Y expression in focal cortical dysplasia and microdysgenesis. Acta Neuropathol (Berl) 105:561-569.
43. Thom M, Martinian L, Sen A, Cross JH, Harding BN, Sisodiya SM (2005): Cortical neuronal densities and lamination in focal cortical dysplasia. Acta Neuropathol (Berl) 110:383-392.
44. Tissir F, Goffinet AM (2003): Reelin and brain development. Nat Rev Neurosci 4:496-505.
45. Tomizawa K, Ohta J, Matsushita M, Moriwaki A, Li ST, Takei K, Matsui H (2002): Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J Neurosci 22:2590-2597.
46. Tomizawa K, Sunada S, Lu YF, Oda Y, Kinuta M, Ohshima T, Saito T, Wei FY, Matsushita M, Li ST, Tsutsui K, Hisanaga S, Mikoshiba K, Takei K, Matsui H (2003): Cophosphorylation of amphiphysin I and dynamin I by Cdk5 regulates clathrin-mediated endocytosis of synaptic vesicles. J Cell Biol 163:813-824.
47. Tseng HC, Zhou Y, Shen Y, Tsai LH (2002): A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains. FEBS Lett 523:58-62.
48. Wang J, Liu S, Fu Y, Wang JH, Lu Y (2003): Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors. Nat Neurosci 6:1039-1047.
49. Weishaupt J, Neusch C, Bahr M (2003): Cyclin-dependent kinase 5 (CDK5) and neuronal cell death. Cell Tissue Res 312:1-8.
50. Wenzel HJ, Robbins CA, Tsai LH, Schwartzkroin PA (2001): Abnormal morphological and functional organization of the hippocampus in a p35 mutant model of cortical dysplasia associated with spontaneous seizures. J Neurosci 21:983-998.
51. Xie F, Padival M, Siegel RE (2007): Association of PSD-95 with ErbB4 facilitates neuregulin signaling in cerebellar granule neurons in culture. J Neurochem 100:62-72.
52. Xie Z, Samuels BA, Tsai LH (2006): Cyclin-dependent kinase 5 permits efficient cytoskeletal remodeling - a hypothesis on neuronal migration. Cereb Cortex 16(suppl 1):i64-i68.
53. Ying Z, Bingaman W, Najm IM (2004): Increased numbers of coassembled PSD-95 to NMDA-receptor subunits NR2B and NR1 in human epileptic cortical dysplasia. Epilepsia 45:314-321.
54. Yoo BC, Lubec G (2001): p25 protein in neurodegeneration. Nature 411:763-764.